Patent details
300078
Product Name:
Olanzapine in amorfe toestand
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300078
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0454436
Status:
Withdrawn
Application number:
300078
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
1
Marketing Authorization Number:
EU/1/96/022/016
Marketing Authorization Type:
EEA
Marketing Authorization Date:
02/07/2001
Marketing Authorization Country:
European Union (EU)
2
Marketing Authorization Number:
EU/1/96/022/018
Marketing Authorization Type:
EEA
Marketing Authorization Date:
02/07/2001
Marketing Authorization Country:
European Union (EU)
3
Marketing Authorization Number:
EU/1/96/022/017
Marketing Authorization Type:
EEA
Marketing Authorization Date:
02/07/2001
Marketing Authorization Country:
European Union (EU)
4
Marketing Authorization Number:
EU/1/96/022/016
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
02/07/2001
Marketing Authorization Country:
European Union (EU)
5
Marketing Authorization Number:
EU/1/96/022/017
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
02/07/2001
Marketing Authorization Country:
European Union (EU)
6
Marketing Authorization Number:
EU/1/96/022/018
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
02/07/2001
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
28/12/2001
First Marketing Authorization date:
02/07/2001
Grant date:
Activation date:
24/04/2011
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
28/12/2001
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
02/05/2002
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
28/12/2001
Name:
Eli Lilly and Company Limited
Address:
Kingsclere Road, RG21 6XA, Basingstoke, Hampshire, United Kingdom (GB)
Agent
Name:
ir. H.V. Mertens c.s.
From:
28/12/2001
Address:
Exter Polak & Charlouis B.V.
Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
MED
Journal edition number:
2002/07
Publication date:
01/07/2002
Description:
Other communications
2
Bulletin Heading:
SPC
Journal edition number:
2002/03
Publication date:
01/03/2002
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
02/05/2002
Incoming Correspondence Paper
Withdrawal of a request
1
PDF
/8/7/0/0/0/0400300078/docs/300078_7_incomingcorrespondencepaper20020502.pdf
14/03/2002
General
2
PDF
/8/7/0/0/0/0400300078/docs/300078_8_spc-documents20020314.pdf
23/01/2002
Outgoing Correspondence
Outgoing Letter
2
PDF
/8/7/0/0/0/0400300078/docs/300078_3_outgoingcorrespondence20020123.pdf
28/12/2001
General
2
PDF
/8/7/0/0/0/0400300078/docs/300078_0_spc-documents20011228.pdf
28/12/2001
General
4
PDF
/8/7/0/0/0/0400300078/docs/300078_1_spc-documents20011228.pdf
28/12/2001
General
1
PDF
/8/7/0/0/0/0400300078/docs/300078_2_spc-documents20011228.pdf
28/12/2001
Application Form
First filed application form
2
PDF
/8/7/0/0/0/0400300078/docs/300078_4_applicationform20011228.pdf
28/12/2001
General
51
PDF
/8/7/0/0/0/0400300078/docs/300078_5_spc-documents20011228.pdf
28/12/2001
General
1
PDF
/8/7/0/0/0/0400300078/docs/300078_6_spc-documents20011228.pdf
28/12/2001
General
2
PDF
/8/7/0/0/0/0400300078/docs/300078_9_spc-documents20011228.pdf